Ellin Berman, MD

Pictured: Ellin Berman

Oncologist and hematologist Ellin Berman describes how a team of experts provides a variety of therapeutic options to patients with leukemia, from standard of care treatments to new therapies available in clinical trials.


I am a board-certified medical oncologist and hematologist with a clinical and research focus on new drug development in acute and chronic leukemias, including acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML). As a member of the multidisciplinary Leukemia Disease Management Team, I work closely with the many individuals who make up the clinical and research programs here.

Along with other members of the Leukemia Service, I am involved in clinical trials of new drugs that hopefully will lead to new treatment approaches for these diseases. I have also worked closely with the Food and Drug Administration in this regard, and for the last 20 years have helped review new drug applications for the treatment of leukemia.

Appointments for New Patients
Clinical Expertise

Acute and Chronic Leukemias; Myelodysplastic Syndromes

Languages Spoken

MD, Harvard Medical School


Boston University Medical Center


Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Hematology; Medical Oncology

Publications by Ellin Berman
Visit PubMed for full listing of Ellin Berman journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.